Published online Aug 10, 2015. doi: 10.4239/wjd.v6.i9.1082
Peer-review started: February 2, 2015
First decision: June 18, 2015
Revised: July 14, 2015
Accepted: July 29, 2015
Article in press: August 3, 2015
Published online: August 10, 2015
Processing time: 197 Days and 6.6 Hours
Glycemic control among critically-ill patients has been a topic of considerable attention for the past 15 years. An initial focus on the potentially deleterious effects of hyperglycemia led to a series of investigations regarding intensive insulin therapy strategies that targeted tight glycemic control. As knowledge accumulated, the pursuit of tight glycemic control among critically-ill patients came to be seen as counterproductive, and moderate glycemic control came to dominate as the standard practice in intensive care units. In recent years, there has been increased focus on the importance of hypoglycemic episodes, glycemic variability, and premorbid diabetic status as factors that contribute to outcomes among critically-ill patients. This review provides a survey of key studies on glucose control in critical care, and aims to deliver perspective regarding glycemic management among critically-ill patients.
Core tip: Glucose control among critically-ill patients has been an area of active research and considerable controversy in the past 15 years. This review provides a practical guide to the evidence, with a survey of the key studies that have informed current perspectives and clinical guidelines related to glycemic management among the critically ill. The article shows why initial enthusiasm for tight glycemic control waned as evidence accumulated favoring more modest glucose goals. The article also summarizes recent work investigating the importance of hypoglycemic episodes, glycemic variability, and premorbid diabetic status on morbidity and mortality in the intensive care unit.